The role of anti-inflammatory therapy in the treatment of acute and chronic prostatitis. Features of innovative ketoprofen molecule. Literature review

Objective. The prevalence of chronic prostatitis in the world ranges from 2.2% to 9.7%. Material. Chronic pelvic pain syndrome in chronic prostatitis is more than 90-95%. erefore, the main place among the drugs for the treatment of acute and chronic prostatitis is occupied by nonsteroidal anti-inflammatory drugs (NSAIDs) for pain relief and inflammation. Results. The emergence of new modified drugs, such as «OKI» - Ketoprofen lysine salt, with high speed, significantly expands the possibilities of complex treatment of prostatitis. Due to good tolerability, and virtually no effect on the gastrointestinal tract. Conclusion. The drug «OKI» - Ketoprofen lysine salt is promising for long - term therapy of chronic prostatitis and other inflammatory diseases in men.